Purchase Order HT001421P0086
Award Date
3/12/21
Potential Completion Date
4/3/25
Potential Value
$85K
Federal Agency
Defense Health Agency
Awardee
Stemcell Technologies Inc.
Ultimate Awardee
Stemcell Tecnologies
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was granted to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies, by the Department of Health and Human Services (HHS). The contract, worth $24,908.80, is a firm fixed-price purchase order for the company to provide a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies, including the...
This federal contract award, valued at $4,356.00, was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The contract is a Firm Fixed Price Purchase Order that runs through October 18, 2024. Stemcell Technologies Inc. is not a small business set-aside, but the company has been awarded some small business set-aside contracts in the past, indicating flexibility in its contracting status. Stemcell Technologies...
The U.S. government awarded a Firm Fixed Price Delivery Order contract to Stemcell Technologies Inc., a Canadian biotechnology company, for the provision of laboratory equipment and supplies. The contract has a ceiling value of $47,405.00 and runs through November 25, 2009. It was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Stemcell Technologies...
This federal contract award, valued at $11,170.80, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which is not set aside for small businesses, is for the provision of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various government agencies, particularly within the Department of...
Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...
This federal contract award was issued by the National Institute of Dental and Craniofacial Research (NIDCR), a civilian agency within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $24,994.77 firm-fixed-price purchase order, awarded on November 6, 2019, is for the delivery of STEMDIFF APEL 2 MEDIUM, a specialized cell culture product used to support biomedical research initiatives. Stemcell...
This federal contract award to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies, is for the delivery of semi-solid culture media. The contract has a ceiling value of $24,664.00 and is a firm fixed price purchase order. The award is set aside for small businesses. Stemcell Technologies Inc. is a key supplier of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives...
Stemcell Technologies Inc., a Canadian biotechnology company, was awarded a $7,485 firm-fixed-price purchase order contract (HHSN272201100756P) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, which does not have a small business set-aside, was awarded on August 10, 2011 with a completion date of July 30, 2012. Stemcell Technologies Inc. primarily...
This is a $6,493.50 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company specializing in cell culture media, cell separation systems, and other life sciences research products. The contract is not set aside for small businesses. Stemcell Technologies Inc. primarily acts as a prime contractor, providing a range of biological materials, laboratory supplies, and specialized...
This federal contract award was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $17,325.95 firm-fixed-price purchase order does not have a set-aside designation. Stemcell Technologies Inc. is a key supplier of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical...